https://data.archives-ouvertes.fr/author/1333

https://data.archives-ouvertes.fr/author/1333

http://xmlns.com/foaf/0.1/topic_interest Multimorbidity
http://xmlns.com/foaf/0.1/topic_interest Traitements hormonaux de la ménopause
http://xmlns.com/foaf/0.1/topic_interest Reproductive aging
http://xmlns.com/foaf/0.1/topic_interest Patterns of use
http://xmlns.com/foaf/0.1/topic_interest EPIC Heart
http://xmlns.com/foaf/0.1/topic_interest Human papillomavirus
http://xmlns.com/foaf/0.1/topic_interest Mediation analysis
http://xmlns.com/foaf/0.1/topic_interest Progestogens
http://xmlns.com/foaf/0.1/topic_interest Age at menopause
http://xmlns.com/foaf/0.1/topic_interest Breast cancer risk
http://xmlns.com/foaf/0.1/topic_interest Transdermal
http://xmlns.com/foaf/0.1/topic_interest Body mass index
http://xmlns.com/foaf/0.1/topic_interest Industrial trans fatty acids
http://xmlns.com/foaf/0.1/topic_interest Inflammation
http://xmlns.com/foaf/0.1/topic_interest Epidémiologie
http://xmlns.com/foaf/0.1/topic_interest Facteur risque
http://xmlns.com/foaf/0.1/topic_interest Oral contraceptives
http://xmlns.com/foaf/0.1/topic_interest Drug claims data
http://xmlns.com/foaf/0.1/topic_interest Ovarian cancer
http://xmlns.com/foaf/0.1/topic_interest Asthma medications
http://xmlns.com/foaf/0.1/mbox_sha1sum 418672394e9a32d9d2f5a638c93944fe
http://xmlns.com/foaf/0.1/topic_interest Diet
http://xmlns.com/foaf/0.1/topic_interest Drug repositioning
http://xmlns.com/foaf/0.1/topic_interest Childhood
http://xmlns.com/foaf/0.1/topic_interest Risk factors
http://xmlns.com/foaf/0.1/topic_interest Molecular status
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.geo
http://xmlns.com/foaf/0.1/topic_interest Femelle
http://xmlns.com/foaf/0.1/topic_interest Machine learning
http://xmlns.com/foaf/0.1/topic_interest Malignant tumor
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.derm
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.em
http://xmlns.com/foaf/0.1/topic_interest Proton pump inhibitors
http://xmlns.com/foaf/0.1/familyName Fournier
http://xmlns.com/foaf/0.1/topic_interest Observation studies
http://xmlns.com/foaf/0.1/name Agnès Fournier
http://xmlns.com/foaf/0.1/topic_interest Nonsteroidal anti-inflammatory drugs
http://xmlns.com/foaf/0.1/topic_interest Cohort studies
http://xmlns.com/foaf/0.1/topic_interest Postmenopausal women
http://xmlns.com/foaf/0.1/topic_interest Arterial hypertension
http://xmlns.com/foaf/0.1/topic_interest Elderly people
http://xmlns.com/foaf/0.1/topic_interest Chronic disease
http://xmlns.com/foaf/0.1/topic_interest Menopause
http://xmlns.com/foaf/0.1/topic_interest Randomized controlled trials
http://xmlns.com/foaf/0.1/topic_interest Parity
http://xmlns.com/foaf/0.1/topic_interest Epidemiology
http://xmlns.com/foaf/0.1/topic_interest E3N
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.aen
http://xmlns.com/foaf/0.1/topic_interest Mammary gland
http://xmlns.com/foaf/0.1/topic_interest Pharmaco-épidémiologie
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.neu
http://xmlns.com/foaf/0.1/topic_interest Adverse events
http://xmlns.com/foaf/0.1/topic_interest Parkinson's disease
http://xmlns.com/foaf/0.1/topic_interest Bias epidemiology
http://xmlns.com/foaf/0.1/topic_interest NUTRITION
http://xmlns.com/foaf/0.1/topic_interest Progesterone
http://xmlns.com/foaf/0.1/topic_interest EUROPEAN PROSPECTIVE INVESTIGATION
http://xmlns.com/foaf/0.1/topic_interest Oral contraceptive
http://xmlns.com/foaf/0.1/topic_interest Medications
http://xmlns.com/foaf/0.1/topic_interest Confounding factors epidemiology
http://xmlns.com/foaf/0.1/topic_interest Progestagen
http://xmlns.com/foaf/0.1/topic_interest Primary prevention
http://xmlns.com/foaf/0.1/topic_interest Estrogens
http://xmlns.com/foaf/0.1/topic_interest Menopausal status
http://xmlns.com/foaf/0.1/topic_interest Mammographic density
http://xmlns.com/foaf/0.1/topic_interest Reproductive factors
http://xmlns.com/foaf/0.1/topic_interest Reverse causation bias
http://xmlns.com/foaf/0.1/topic_interest Tumeur maligne
http://xmlns.com/foaf/0.1/topic_interest Asthma
http://xmlns.com/foaf/0.1/topic_interest Drug repurposing
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.can
http://xmlns.com/foaf/0.1/topic_interest Risque
http://xmlns.com/foaf/0.1/topic_interest Risk
http://xmlns.com/foaf/0.1/topic_interest Psoriasis
http://xmlns.com/foaf/0.1/topic_interest Glucocorticoids
http://xmlns.com/foaf/0.1/topic_interest Nutritional status
http://xmlns.com/foaf/0.1/topic_interest French national health data system
http://xmlns.com/foaf/0.1/topic_interest Cohort
http://xmlns.com/foaf/0.1/topic_interest PRINCIPAL COMPONENT ANALYSIS
http://xmlns.com/foaf/0.1/topic_interest Pharmacoepidemiology
http://xmlns.com/foaf/0.1/topic_interest ER-receptor
http://www.openarchives.org/ore/terms/isAggregatedBy https://data.archives-ouvertes.fr/author/agnes-fournier
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.bdlr
http://xmlns.com/foaf/0.1/topic_interest Femme
http://xmlns.com/foaf/0.1/topic_interest Breast cancer
http://www.w3.org/2002/07/owl#sameAs 0000-0001-8380-3439
http://xmlns.com/foaf/0.1/topic_interest Anthropometry
http://www.w3.org/2002/07/owl#sameAs 122547527
http://xmlns.com/foaf/0.1/topic_interest Mycoplasma genitalium
http://xmlns.com/foaf/0.1/topic_interest Prospective study
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.sp.pharma
http://xmlns.com/foaf/0.1/firstName Agnès
http://xmlns.com/foaf/0.1/topic_interest Female
http://xmlns.com/foaf/0.1/topic_interest Endometrial cancer
http://xmlns.com/foaf/0.1/topic_interest Homme
http://xmlns.com/foaf/0.1/topic_interest Menopausal symptoms
http://xmlns.com/foaf/0.1/topic_interest PR-receptor
http://xmlns.com/foaf/0.1/topic_interest Adult diabetes
http://xmlns.com/foaf/0.1/topic_interest Human
http://xmlns.com/foaf/0.1/topic_interest Dydrogesterone
http://xmlns.com/foaf/0.1/topic_interest Cancer du sein
http://xmlns.com/foaf/0.1/topic_interest EPIDEMIOLOGIE
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.spee
http://xmlns.com/foaf/0.1/topic_interest Asthma phenotypes
http://xmlns.com/foaf/0.1/topic_interest Health behaviours
http://xmlns.com/foaf/0.1/topic_interest NUTRIENT PATTERNS
http://xmlns.com/foaf/0.1/topic_interest MORPH3Eus
http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://xmlns.com/foaf/0.1/Person
http://xmlns.com/foaf/0.1/topic_interest Progestagens
http://xmlns.com/foaf/0.1/topic_interest Hormonal exposure
http://xmlns.com/foaf/0.1/topic_interest Menopausal hormone therapy
http://xmlns.com/foaf/0.1/topic_interest Biomarkers
http://xmlns.com/foaf/0.1/topic_interest Chlamydia trachomatis
http://xmlns.com/foaf/0.1/topic_interest Cancer stage
http://xmlns.com/foaf/0.1/topic_interest Oral
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.imm.all
http://xmlns.com/foaf/0.1/topic_interest Hormone replacement therapy
http://xmlns.com/foaf/0.1/topic_interest Oestrogen receptors
http://xmlns.com/foaf/0.1/topic_interest Cohort study
http://xmlns.com/foaf/0.1/topic_interest Postmenopause
http://xmlns.com/foaf/0.1/topic_interest Estrogen
http://xmlns.com/foaf/0.1/topic_interest Omega 3
http://xmlns.com/foaf/0.1/topic_interest Glande mammaire
http://xmlns.com/foaf/0.1/topic_interest Parkinson disease
http://xmlns.com/foaf/0.1/topic_interest Cancer
http://xmlns.com/foaf/0.1/topic_interest Artificial and natural menopause
http://xmlns.com/foaf/0.1/topic_interest Herpes simplex virus
http://xmlns.com/foaf/0.1/topic_interest Epidemiologic

Télécharger au format